Aiken, Alexander M, Nyamwaya, Brian, Madrid, Lola, Edessa, Dumessa, Labi, Appiah-Korang, Obeng-Nkrumah, Noah, Mwabaya, William, Chimenya, Mabvuto, Cocker, Derek, Iregbu, Kenneth C, Princewill-Nwajiobi, Philip I P, Dramowski, Angela, Sonda, Tolbert, Mmbaga, Blandina Theophil, Ojok, David, Fwoloshi, Sombo, Scott, J Anthony G and Whitelaw, Andrew (2023) 'Circumstances for treatment and control of invasive Enterobacterales infections in eight hospitals across sub-Saharan Africa: a cross-sectional study.'. Gates Open Research, Vol 7, p. 21.
|
Text
PMC10963387.pdf - Published Version Available under License Creative Commons Attribution. Download (703kB) | Preview |
Abstract
Background: Bloodstream infections caused by Enterobacterales show high frequency of antimicrobial resistance (AMR) in many Low- and Middle-Income Countries. We aimed to describe the variation in circumstances for management of such resistant infections in a group of African public-sector hospitals participating in a major research study.
Methods: We gathered data from eight hospitals across sub-Saharan Africa to describe hospital services, infection prevention and antibiotic stewardship activities, using two WHO-generated tools. We collected monthly cross-sectional data on availability of antibiotics in the hospital pharmacies for bloodstream infections caused by Enterobacterales. We compared the availability of these antibiotics to actual patient-level use of antibiotics in confirmed Enterobacterales bloodstream infections (BSI).
Results: Hospital circumstances for institutional management of resistant BSI varied markedly. This included self-evaluated infection prevention level (WHO-IPCAF score: median 428, range 155 to 687.5) and antibiotic stewardship activities (WHO stewardship toolkit questions: median 14.5, range 2 to 23). These results did not correlate with national income levels. Across all sites, ceftriaxone and ciprofloxacin were the most consistently available antibiotic agents, followed by amoxicillin, co-amoxiclav, gentamicin and co-trimoxazole. There was substantial variation in the availability of some antibiotics, especially carbapenems, amikacin and piperacillin-tazobactam with degree of access linked to national income level. Investigators described out-of-pocket payments for access to additional antibiotics at 7/8 sites. The in-pharmacy availability of antibiotics correlated well with actual use of antibiotics for treating BSI patients.
Conclusions: There was wide variation between these African hospitals for a range of important circumstances relating to treatment and control of severe bacterial infections, though these did not all correspond to national income level. For most antibiotics, patient-level use reflected in-hospital drug availability, suggesting external antibiotics supply was infrequent. Antimicrobial resistant bacterial infections could plausibly show different clinical impacts across sub-Saharan Africa due to this contextual variation.
Item Type: | Article | ||||
---|---|---|---|---|---|
Subjects: | WC Communicable Diseases > WC 20 Research (General) WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 260 Enterobacteriaceae and other enteric infections WX Hospitals and Other Health Facilities > Hospital Administration > WX 167 Cross infection prevention and control |
||||
Repository link: |
|
||||
Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department | ||||
Digital Object Identifer (DOI): | https://doi.org/10.12688/gatesopenres.14267.1 | ||||
SWORD Depositor: | JISC Pubrouter | ||||
Depositing User: | JISC Pubrouter | ||||
Date Deposited: | 18 Apr 2024 09:32 | ||||
Last Modified: | 18 Apr 2024 09:40 | ||||
URI: | https://archive.lstmed.ac.uk/id/eprint/24328 |
Statistics
Actions (login required)
Edit Item |